Screener
UroGen Pharma URGN Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from UroGen Pharma’s reported figures.
Based on trailing twelve months.
The source filing: UroGen Pharma’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 8:05 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-025794
FAQ
- What is UroGen Pharma's free cash flow margin?
- UroGen Pharma (URGN) reported free cash flow margin of -84.3% in Q2 2026.
- How has UroGen Pharma's free cash flow margin changed year-over-year?
- UroGen Pharma's free cash flow margin increased by 35.7% year-over-year, from -131.1% to -84.3%.
- What is the long-term trend for UroGen Pharma's free cash flow margin?
- Over 5 years (2020 to 2025), UroGen Pharma's free cash flow margin has grown at a -30.4% compound annual growth rate (CAGR), from -907.7% to -148.2%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.
Ask your AI about UroGen Pharma's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude